Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-07

FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for pantoprazole sodium from Mylan Pharmaceuticals Inc. under ANDA090970, allowing continued marketing of the generic pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)